REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Silimed Colombia S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Silimed Colombia S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Silimed Colombia S.A.S is an enterprise located in Colombia, with the main office in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. The company was established on November 10, 2017. There are currently 6 (2024) people employed by Silimed Colombia S.A.S. From the latest financial highlights, Silimed Colombia S.A.S reported a net sales revenue increase of 40.63% in 2023. Its’ total assets recorded a growth of 57.73%.

Headquarters
Cra 18A 103 11
Bogota D.C.; Bogota D.C; Postal Code: 0815

Contact Details: Purchase the Silimed Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Silimed Colombia S.A.S report to view the information.
Outstanding Shares:
Purchase the Silimed Colombia S.A.S report to view the information.
Incorporation Date:
November 10, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Silimed Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
40.63%▲
Total operating revenue
40.63%▲
Operating profit (EBIT)
184.27%▲
Net Profit (Loss) for the Period
N/A
Total assets
57.73%▲
Total equity
N/A
Operating Profit Margin (ROS)
10.5%▲
Net Profit Margin
N/A
Return on Equity (ROE)
185.94%▲
Quick Ratio
0.37%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo